Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,492,328
-$150,008 QoQ
Shares Held
11,812
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#927
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENEDICT FINANCIAL ADVISORS INC holds $49,408,945 across 8 Drug Manufacturers - General names. GILD ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,991 | $15,489,884 | |
| 2 | AMGN |
Amgen Inc
|
33,255 | $12,042,300 | |
| 3 | ABBV |
AbbVie Inc.
|
47,038 | $11,836,642 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
70,088 | $4,038,470 | |
| 5 | NVS |
Novartis AG
|
17,055 | $2,672,859 | |
| 6 | NVO |
Novo Nordisk A S
|
33,754 | $1,618,166 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
11,812 | $1,492,328 | |
| 8 | LLY |
ELI LILLY & Co
|
182 | $218,296 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,492,328 | 11,812 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,642,336 | 11,784 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,485,399 | 12,102 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,377,954 | 12,414 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,371,572 | 12,371 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,381,128 | 12,326 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,145,203 | 12,398 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,035,004 | 12,345 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $858,516 | 12,513 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $919,067 | 12,547 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,014,812 | 12,527 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $933,827 | 12,461 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $956,284 | 12,408 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,025,343 | 12,358 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,055,611 | 12,296 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $758,663 | 12,298 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $870,037 | 14,076 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $897,813 | 15,102 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,263,777 | 17,405 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,234,808 | 17,678 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,238,378 | 17,984 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,236,824 | 19,137 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,174,346 | 20,157 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,281,050 | 20,273 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,594,427 | 20,723 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,542,523 | 20,633 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||